Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.
The treatment of schizophrenia changed drastically with the discovery of antipsychotic medications in the 1950s, the release of clozapine in the US in 1989 and the subsequent development of the atypical or novel antipsychotics. These newer medications differ from their conventional counterparts, primarily based on their reduced risk of extrapyramidal symptoms (EPS). EPS can be categorised as acute (dystonia, akathisia and parkinsonism) and tardive (tardive dyskinesia and tardive dystonia) syndromes. They are thought to have a significant impact on subjective tolerability and adherence with antipsychotic therapy in addition to impacting function. Unlike conventional antipsychotic medications, atypical antipsychotics have a significantly diminished risk of inducing acute EPS at recommended dose ranges. These drugs may also have a reduced risk of causing tardive dyskinesia and in some cases may have the ability to suppress pre-existing tardive dyskinesia. This paper reviews the available evidence regarding the incidence of acute EPS and tardive syndromes with atypical antipsychotic therapy. Estimates of incidence are subject to several confounds, including differing methods for detection and diagnosis of EPS, pretreatment effects and issues surrounding the administration of antipsychotic medications. The treatment of acute EPS and tardive dyskinesia now includes atypical antipsychotic therapy itself, although other adjunctive strategies such as antioxidants have also shown promise in preliminary trials. The use of atypical antipsychotics as first line therapy for the treatment of schizophrenia is based largely on their reduced risk of EPS compared with conventional antipsychotics. Nevertheless, EPS with these drugs can occur, particularly when prescribed at high doses. The EPS advantages offered by the atypical antipsychotics must be balanced against other important adverse effects, such as weight gain and diabetes mellitus, now known to be associated with these drugs.
Pierre
Joseph M
JM
David Geffen School of Medicine at UCLA, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA. joseph.pierre2@med.va.gov
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*; D006801:Humans
D014150:Antipsychotic Agents
Arch Gen Psychiatry. 1988 Jan;45(1):79-91
2892478
Drug Saf. 2000 Jan;22(1):73-81
10647977
Ann Pharmacother. 2000 Dec;34(12):1487-8
11144710
J Clin Psychopharmacol. 1987 Aug;7(4):243-6
3624506
Am J Psychiatry. 2000 Jul;157(7):1150-5
10873925
Psychiatr Prax. 2002 Sep;29(6):315-7
12224042
J Clin Psychiatry. 1989 Apr;50(4):132-5
2925601
Int J Neuropsychopharmacol. 1999 Dec;2(4):333-334
11285150
Int Clin Psychopharmacol. 2002 Sep;17(5):263-4
12177588
Cochrane Database Syst Rev. 2000;(2):CD000209
10796508
Br J Psychiatry. 1999 Jan;174:23-30
10211147
Int Clin Psychopharmacol. 2001 Nov;16(6):369-71
11712627
J Clin Psychiatry. 1996 Apr;57(4):167-73
8601552
Psychopharmacol Bull. 1995;31(2):259-64
7491377
Am J Psychiatry. 2004 Mar;161(3):414-25
14992963
Arch Gen Psychiatry. 1988 Sep;45(9):789-96
3046553
J Clin Psychopharmacol. 1999 Jun;19(3):276-7
10350038
Am J Psychiatry. 1999 Jul;156(7):990-9
10401441
J Clin Psychiatry. 1996 Oct;57(10):449-54
8909330
Schizophr Bull. 2002;28(1):31-42
12047020
Schizophr Bull. 1997;23(4):583-609
9365997
J Clin Psychopharmacol. 1997 Aug;17(4):308-13
9241011
Eur Psychiatry. 2003 Aug;18(5):260-1
12927329
Am J Psychiatry. 2002 Aug;159(8):1436
12153846
Ann Clin Psychiatry. 1998 Sep;10(3):101-5
9781472
J Clin Psychiatry. 1999 Nov;60(11):771-5
10584767
J Clin Psychopharmacol. 1999 Feb;19(1):100-1
9934952
Arch Gen Psychiatry. 1991 Aug;48(8):739-45
1883257
Schizophr Res. 1999 Aug 23;39(1):1-16; discussion 17-8
10480663
Arch Neurol. 2002 Jul;59(7):1125-32
12117360
Ann Intern Med. 1999 Jul 6;131(1):72
10391826
Pharmacopsychiatry. 1998 Mar;31(2):68-9
9562211
J Clin Psychiatry. 1999 May;60(5):340-1
10362448
J Clin Psychopharmacol. 1998 Aug;18(4):296-304
9690695
Am J Psychiatry. 2001 Mar;158(3):360-9
11229973
J Clin Psychopharmacol. 1987 Dec;7(6):377-84
3323261
Mov Disord. 1999 Jul;14(4):652-7
10435503
Biol Psychiatry. 1998 Jun 15;43(12):868-72
9627740
Schizophr Res. 2001 Mar 1;47(2-3):309-10
11322143
Schizophr Bull. 1988;14(2):291-6
2904696
Neurology. 1982 May;32(5):558-9
6122190
J Clin Psychopharmacol. 1997 Jun;17(3):194-201
9169965
Schizophr Bull. 2002;28(1):17-29
12047017
Am J Psychiatry. 1999 May;156(5):796-7
10327920
Am J Psychiatry. 1997 Sep;154(9):1248-54
9286184
Eur Psychiatry. 2000 Nov;15(7):438-9
11112937
Biol Psychiatry. 1993 May 15;33(10):700-6
8102552
Arch Gen Psychiatry. 1997 Jun;54(6):549-57
9193196
Br J Psychiatry. 1989 May;154:672-6
2574607
J Clin Psychopharmacol. 1995 Feb;15(1 Suppl 1):36S-44S
7537286
Biol Psychiatry. 1999 Mar 15;45(6):715-30
10188001
J Clin Psychopharmacol. 1989 Dec;9(6):407-11
2574192
Clin Ther. 2001 Nov;23(11):1839-54
11768836
J Clin Psychiatry. 1997 Jul;58(7):318-22
9269253
J Clin Psychiatry. 1999;60 Suppl 12:22-3
10372606
Ann Clin Psychiatry. 1996 Mar;8(1):27-9
8743646
Am J Psychiatry. 1994 Jun;151(6):825-35
7514366
Arch Gen Psychiatry. 1999 Sep;56(9):836-41
12892048
J Clin Psychiatry. 1999 Dec;60(12 ):870
10665640
J Clin Psychopharmacol. 1995 Feb;15(1 Suppl 1):45S-51S
7537287
J Pharmacol Exp Ther. 1992 Aug;262(2):699-706
1380082
Arch Gen Psychiatry. 1982 Jul;39(7):803-16
6131655
Int Clin Psychopharmacol. 2000 Jan;15(1):57-60
10836289
Neuropsychopharmacology. 1999 May;20(5):491-505
10192829
J Clin Psychiatry. 1998 Jan;59(1):29-30
9491064
Can J Psychiatry. 1990 Oct;35(7):576-80
1980092
Am J Psychiatry. 1992 Mar;149(3):391-3
1346951
J Clin Psychiatry. 1993 Sep;54(9):327-30
8104929
Eur Psychiatry. 2000 Aug;15(5):338-9
10954879
Eur Psychiatry. 2002 Nov;17 (7):421-4
12547311
Eur Neuropsychopharmacol. 1999 Jun;9(4):367-8
10422899
Am J Psychiatry. 2001 Oct;158(10):1737
11579018
Ann Pharmacother. 2001 Dec;35(12 ):1517-22
11793611
J Clin Psychiatry. 2001 Apr;62(4):298-9
11379849
J Clin Psychiatry. 1987 Jul;48(7):263-7
2885310
Acta Psychiatr Scand. 1999 Mar;99(3):160-70
10100910
Schizophr Res. 2003 Jun 1;61(2-3):123-36
12729864
Psychopharmacology (Berl). 1978 Jan 31;56(1):75-80
415329
J Clin Psychopharmacol. 1997 Oct;17 (5):407-18
9315992
J Clin Psychiatry. 2000;61 Suppl 4:45-57
10739331
Schizophr Res. 2000 Dec 15;46(2-3):107-9
11120422
Arch Gen Psychiatry. 2001 Nov;58(11):1049-52
11695951
N Engl J Med. 2002 Jan 3;346(1):16-22
11777998
Am J Psychiatry. 1992 Jun;149(6):773-7
1350428
Psychiatr Clin North Am. 2003 Mar;26(1):165-90
12683265
J Nerv Ment Dis. 1985 Jun;173(6):353-7
3998720
Am J Psychiatry. 1993 Sep;150(9):1405-7
8102511
Aust N Z J Psychiatry. 2000 Jun;34(3):355-69
10881961
Pharmacopsychiatry. 2000 Jul;33(4):155-6
10958268
J Am Geriatr Soc. 1999 Jun;47(6):716-9
10366172
J Clin Psychopharmacol. 1993 Feb;13(1):25-40
7683702
J Med Assoc Thai. 2000 Nov;83(11):1430-2
11215878
Cochrane Database Syst Rev. 2001;(4):CD000209
11687073
J Clin Psychopharmacol. 2001 Aug;21(4):375-81
11476121
Arch Gen Psychiatry. 2000 Jun;57(6):553-9
10839333
Br J Psychiatry. 1999 Oct;175:391-2
10789313
Arch Gen Psychiatry. 1990 Aug;47(8):754-8
2378546
Clin Neuropharmacol. 2002 Mar-Apr;25(2):71-4
11981231
Clin Neuropharmacol. 1998 Jan-Feb;21(1):68-9
9579290
J Clin Psychiatry. 2000;61 Suppl 4:39-44
10739330
Acta Psychiatr Scand Suppl. 1994;382:11-5
7916523
Am J Psychiatry. 1990 Apr;147(4):505-6
1969247
J Clin Psychiatry. 1995 Oct;56(10):484-5
7559377
J Clin Psychiatry. 2002 Sep;63(9):763-71
12363115
Biol Psychiatry. 1994 Jun 1;35(11):886-7
8054412
Schizophr Bull. 1999;25(4):741-8
10667744
Psychopharmacology (Berl). 1998 Nov;140(2):173-84
9860108
Schizophr Bull. 1997;23(4):663-74
9366002
J Clin Psychiatry. 1998 Jul;59(7):380-1
9714267
Eur Arch Psychiatry Clin Neurosci. 1998;248(4):209-11
9810484
Psychopharmacology (Berl). 2000 Jan;148(1):3-15
10663410
JAMA. 1961 Mar 25;175:1054-60
13685365
J Postgrad Med. 1993 Jul-Sep;39(3):124-6
7914238
Am J Psychiatry. 1996 May;153(5):734-5
8615429
J Nerv Ment Dis. 1994 Feb;182(2):113-4
8308529
Can J Psychiatry. 1999 Jun;44(5):507-8
10389620
Prog Neuropsychopharmacol Biol Psychiatry. 1996 Feb;20(2):263-74
8861192
J Clin Psychiatry. 2002 Feb;63(2):167-8
11874222
J Clin Psychiatry. 2002 Jun;63(6):516-23
12088164
Am J Psychiatry. 1999 Dec;156(12 ):2016
10588425
Harv Rev Psychiatry. 2002 Sep-Oct;10(5):280-91
12202454
Biol Psychiatry. 1997 Aug 15;42(4):233-46
9270900
J Clin Psychiatry. 1998 Sep;59(9):472-7
9771818
J Clin Psychiatry. 1997 May;58(5):205-11
9184614
Arch Gen Psychiatry. 1982 Apr;39(4):486-7
6121550
Lancet. 2003 May 10;361(9369):1581-9
12747876
Am J Psychiatry. 2001 May;158(5):765-74
11329400
Br J Psychiatry. 1991 Apr;158:503-10
1675900
Am J Psychiatry. 1999 Aug;156(8):1290
10450277
J Clin Psychiatry. 1994 Sep;55 Suppl B:102-6
7961550
Am J Psychiatry. 1996 Jun;153(6):843
8633711
J Pharmacol Exp Ther. 1989 Oct;251(1):238-46
2571717
Schizophr Res. 1999 Mar 1;35 Suppl:S61-6
10190226
Schizophr Bull. 1999;25(4):731-40
10667743
Schizophr Res. 1997 Dec 19;28(2-3):231-46
9468357
Am J Psychiatry. 1994 Jun;151(6):925-6
8185007
Arch Gen Psychiatry. 1993 Sep;50(9):723-33
8102845
J Am Acad Child Adolesc Psychiatry. 1996 Nov;35(11):1421-2
8936904
J Psychosoc Nurs Ment Health Serv. 1993 Sep;31(9):14-8
7901407
Psychopharmacology (Berl). 1982;77(2):105-8
6812127
Biol Psychiatry. 1999 Jun 15;45(12):1630-5
10376125
Arch Gen Psychiatry. 1998 Mar;55(3):279-80
9510225
Acta Psychiatr Scand Suppl. 1970;212:11-9
4917967
J Clin Psychiatry. 2001;62 Suppl 21:15-8
11584982
S D J Med. 2000 Feb;53(2):65-7
10731859
Eur Psychiatry. 1999 Jul;14(4):245-7
10572353
Biol Psychiatry. 1997 Jan 1;41(1):114-6
8988802
Med Health R I. 1998 Aug;81(8):271-2
9727307
Int Clin Psychopharmacol. 1998 Jul;13(4):147-55
9727725
Schizophr Res. 1999 Jan 4;35(1):51-68
9988841
Neurol Sci. 2001 Aug;22(4):331-2
11808858
Can J Psychiatry. 2000 Mar;45(2):202
10742889
Br J Psychiatry. 1995 Jun;166(6):712-26; discussion 727-33
7545060
Am J Psychiatry. 2003 Mar;160(3):588
12611849
J Clin Psychiatry. 1999;60 Suppl 10:15-9
10340683
BMJ. 2000 Dec 2;321(7273):1371-6
11099280